cp-55,940 has been researched along with orlistat in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fowler, CJ; Lambert, DM | 1 |
| Berg, R; Burch, P; Chicca, A; Gademann, K; Gertsch, J; Jessen, HJ; Marck, N; Schmid, F | 1 |
1 review(s) available for cp-55,940 and orlistat
| Article | Year |
|---|---|
The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications.
Topics: Amides; Amidohydrolases; Amines; Animals; Arachidonic Acids; Binding Sites; Cannabinoid Receptor Modulators; Drug Design; Endocannabinoids; Esters; Ethers; Glycerides; Humans; Ligands; Monoacylglycerol Lipases; Polyunsaturated Alkamides; Receptors, Cannabinoid | 2005 |
1 other study(ies) available for cp-55,940 and orlistat
| Article | Year |
|---|---|
Biological evaluation of pyridone alkaloids on the endocannabinoid system.
Topics: Alkaloids; Amidohydrolases; Arachidonic Acids; Cyclooxygenase 2; Endocannabinoids; Humans; Inhibitory Concentration 50; Kinetics; Monoacylglycerol Lipases; Polyunsaturated Alkamides; Protein Binding; Pyridones; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; U937 Cells | 2017 |